Mistakes in mismatch repair genes may accurately predict response to certain immunotherapy drugs

Posted on by admin

In a report of a proof-of-principle study of patients with colon and other cancers for whom standard therapies failed, researchers at the Johns Hopkins Kimmel Cancer Center say that mistakes in so-called mismatch repair genes, first identified by Johns Hopkins and other scientists two decades ago, may accurately predict who will respond to certain immunotherapy drugs known as PD-1 inhibitors. Such drugs aim to disarm systems developed by cancer cells to evade detection and destruction by immune system cells.
SOURCE: The Medical News – Read entire story here.

Related posts:

  1. Lipid Nanoparticle Therapeutic Treats Ebola in Monkeys Lipid Nanoparticle Therapeutic Treats Ebola in MonkeysA newly designed agent was effective in treating monkeys infected with a deadly Ebola virus strain. The therapy is now being tested in Sierra Leone in people infected with Ebola. ...
  2. Insights into Energy-Burning Fat Cells Insights into Energy-Burning Fat CellsResearchers identified beige fat cells, which burn energy rather than store it, in humans. The finding may lead to new ways to engineer fat cells to fight obesity. ...
  3. The Top 10 Biotech Companies In The U.S. SOURCE: Forbes – Health – Read entire story here. ...
  4. An Evolving Diabetes Online Community Just a few short years ago, no one could have envisioned the Diabetes Online Community would become what it is today. And be moving in the collaborative direction it's going...Seriously, some likely would have laughed at the idea while shaking the... ...
  5. Anticoagulant medications: Newer, easier to manage medications may not always be the best choice If you are over age 75, and taking an anticoagulant, the old standard may be the gold standard, Mayo Clinic researchers and collaborators have determined. ...

Related Posts